Literature DB >> 9876774

Airway remodeling: potential contributions of subepithelial fibrosis and airway smooth muscle hypertrophy/hyperplasia to airway narrowing in asthma.

A M Bento1, M B Hershenson.   

Abstract

Recently, much attention has been focused on the airway structural changes accompanying chronic, severe asthma, and the potential ramifications of these changes for airway function and medical management. Airway remodeling may exaggerate airway narrowing by: (i) thickening of the airway wall internal to the smooth muscle, thereby increasing the luminal obstruction generated by a given degree of smooth muscle shortening; (ii) increasing the amount of smooth muscle, thereby increasing shortening; and/or (iii) reducing the load on the smooth muscle, either by increasing the compliance of the airway wall or by reducing airway-parenchymal interdependence. The possibility also exists that airway remodeling represents a protective mechanism against excessive airway narrowing. The major airway structural changes occurring in asthma are subepithelial protein deposition and increased airway smooth muscle mass (hypertrophy, hyperplasia, or both). Several investigators have found correlations between the magnitudes of subepithelial thickening and smooth muscle hypertrophy/hyperplasia and the severity of airways disease, though interpretation has been made difficult by study differences in patient population, treatment, indices of disease severity, and morphometric technique. Taken together, these data suggest that increases in airway remodeling may contribute significantly to the airflow obstruction observed in patients with asthma. However, data proving a causal relationship between airway remodeling and asthma severity remain elusive.

Entities:  

Mesh:

Year:  1998        PMID: 9876774     DOI: 10.2500/108854198778612672

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  6 in total

Review 1.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Targeted HAS2 Expression Lessens Airway Responsiveness in Chronic Murine Allergic Airway Disease.

Authors:  Julia K L Walker; Barbara S Theriot; Michael Ghio; Carol S Trempus; Jordan E Wong; Victoria L McQuade; Jiurong Liang; Dianhua Jiang; Paul W Noble; Stavros Garantziotis; Monica Kraft; Jennifer L Ingram
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

3.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Authors:  M G Chiaramonte; D D Donaldson; A W Cheever; T A Wynn
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 4.  Airway remodeling: lessons from animal models.

Authors:  David Ramos-Barbón; Mara S Ludwig; James G Martin
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

5.  Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis.

Authors:  Cordula Koerner-Rettberg; Sandra Doths; Anke Stroet; Jürgen Schwarze
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

Review 6.  Pathology of asthma.

Authors:  Makoto Kudo; Yoshiaki Ishigatsubo; Ichiro Aoki
Journal:  Front Microbiol       Date:  2013-09-10       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.